Precision medicine and companion diagnostics for oncologists – testing, reporting and actionability

Molecular profiling of tumours to identify targetable alterations is rapidly developing and is now part of clinical practice for a range of cancers. Genomic testing needs a co-ordinated approach to specimen collection, testing and reporting, and it’s important to be aware of the types of genomic variants reported by the laboratory and the technology used ...

Already a member?

Login to keep reading.

© 2022 the limbic